Skip to main content

Partner Platforms

Access our research through your preferred platform

null

ESG considerations are increasingly important to investment decisions, driving the need for access to high quality research and data on leading investor and public platforms.

Sustainalytics works with several partners to make our ESG research and data available. This expands investors’ access to our research by enabling them to view it through the tools they already use. It also facilitates ESG integration by making ESG data available alongside financial information and enables sophisticated use cases through the functionalities these platforms support.

 

Institutional Investor Platforms

Aladdin

Bloomberg Data Management

Factset

IHS Markit

Morningstar

Rimes

StyleAnalytics

Retail and Public Platforms

Scotia iTrade

Yahoo! Finance

Are you interested in integrating Sustainalytics’ research into your platform?

Why Sustainalytics?

null

A Single Market Standard

Consistent approach to ESG assessments across the investment spectrum.

null

Award-Winning Research and Data

Firm recognized as Best ESG Research and Data Provider by Environmental Finance and Investment Week.

null

End-to-End ESG Solutions

ESG products and services that serve the entire investment value chain.

null

30 Years of ESG Expertise

800+ ESG research analysts across our global offices.

null

A Leading SPO Provider

As recognized by Environmental Finance and the Climate Bonds Initiative.

Related Insights and Resources

Biodiversity in the Balance Revisited | Sustainalytics

Biodiversity in the Balance: Revisiting Portfolio Risks

On the occasion of COP16, this article updates previous research from Morningstar Sustainalytics showing how investing in companies facing high levels of risk associated with biodiversity loss can have a material effect on long-term portfolio performance.

Green Buildings on the Rise | Morningstar Sustainalytcs

Green Buildings on the Rise: Why Building Products Matter

This article explains the role of building products companies in the global green building transition and why investors should consider them as part of their sustainable portfolios.

GLP-1 Medications for Cosmetic Weight Loss and Diabetes | Sustainalytics

Why Looks Could Kill: An ESG Perspective on GLP-1 Medications for Cosmetic Weight Loss and Diabetes

GLP-1 medications' proven efficacy for weight loss caused global demand for these treatments to soar. While the heightened demand is promising for biopharmaceutical companies, it also introduces an array of ESG challenges that this article explores.

Navigating Material Climate Risks in the Global Equities Market

Navigating Material Climate Risks in the Global Equities Market

This report evaluates companies on the Morningstar Global Large-Mid Cap Equities Index and how they are misaligned to net zero targets. It also identifies industry challenges regarding emissions reporting and their solutions.

Related Solutions

null

API & Datafeed Solutions

Integrate our research directly into your systems and work processes through a variety of data deliverables. 

Learn More
null

Global Access

Sustainalytics’ online platform enables you to access our research through a user-friendly interface with robust screening, monitoring and reporting tools. 

Learn More